Yesterday, Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) saw four of its insiders complete stock dispositions. The first three insiders to unload stock were James Barrett, Patrick Kerins, and Peter Barris, all of whom own over 10% of the company. Consequentially, all three insiders sold 35,540 shares of Common Stock yesterday. The stock was sold indirectly through NEA Partners 12 and for a weighted average price of $6.76 per share in all three cases. Furthermore, all three insiders had already disposed of 675,000 shares of Common Stock on Friday, receiving $6.62 per share.
The fourth insider at the $412.2 million market cap biopharmaceutical firm to unload stock yesterday was Director and 10% owner, Dayton Misfeldt. The director sold 37,100 shares of Common Stock, indirectly via Bay City Capital LLC and received $6.77 per share, just one day after having disposed of 31,600 shares for a weighted average price of $6.90 per share. The insider had also unloaded 675,000 shares of Common Stock on Friday for a price of $6.62 per share.
Disclosure: none
Suggested Articles:
Healthiest Countries in the World
Highest Suicide Rates By Profession
